GlassScriptPhysician profile
Craig B Hunter
NPI 1508095753
$10,118.23
in general payments reported to CMS, 2019-2025
36 companies · $1,518 in 2025
The $1,518 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,064 · 2020: $727 · 2021: $1,220 · 2022: $795 · 2023: $2,021 · 2024: $2,773 · 2025: $1,518.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,169 · Travel and Lodging: $1,982 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $125 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,169.26 |
| Travel and Lodging | $1,981.87 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $124.97 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $2,333.65 | 2019-2025 | Titan, Speedicath |
| Uromedica, Incorporated | $1,603.91 | 2024 | Proact |
| Procept Biorobotics Corporation | $1,494.79 | 2022-2025 | Aquabeam Robotic System, Aquabeam System |
| Boston Scientific Corporation | $892.59 | 2019-2025 | Lithovue, General - Erectile Dysfunction |
| Sumitomo Pharma America, INC. | $377.25 | 2023-2025 | Gemtesa, Orgovyx |
| Telix Pharmaceuticals | $373.43 | 2024-2025 | Illuccix |
| Axonics, INC. | $349.00 | 2023 | Axonics, Bulkamid |
| Astellas Pharma US INC | $311.45 | 2019-2025 | Xtandi, Veozah |
| Urogen Pharma, INC. | $303.13 | 2022-2025 | |
| Dendreon Pharmaceuticals LLC | $256.39 | 2020-2025 | Provenge |
| Abbvie INC. | $192.29 | 2023-2025 | |
| Endo Pharmaceuticals INC. | $179.42 | 2019-2024 | Xiaflex |
| Swan Valley Medical Incorporated | $140.81 | 2019 | |
| Pfizer INC. | $130.78 | 2019-2025 | |
| Laborie Medical Technologies Corp. | $129.01 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urovant Sciences INC | $125.00 | 2021 | |
| Ferring Pharmaceuticals INC. | $121.35 | 2019-2025 | Adstiladrin |
| Olympus America INC. | $116.97 | 2019 | |
| Endo USA, INC. | $100.81 | 2024-2025 | Xiaflex, Aveed |
| 180 Medical, INC. | $64.36 | 2019-2025 | Gentlecath |
| Accord Healthcare, INC. | $64.14 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $62.08 | 2024 | Keytruda, Welireg |
| Antares Pharma, INC. | $56.60 | 2019-2025 | Xyosted |
| Innovation Technologies INC | $45.47 | 2024 | Irrisept |
| Blue Earth Diagnostics | $39.95 | 2025 | Posluma |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Lsi Solutions INC | $34.87 | 2024 | Jnw Urtrac |
| Medtronic, INC. | $33.12 | 2022-2023 | Interstim |
| Teleflex LLC | $26.83 | 2023 | Urolift |
| Bayer Healthcare Pharmaceuticals INC. | $21.76 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $21.34 | 2022 | |
| Myriad Genetic Laboratories, INC. | $18.06 | 2021 | |
| Immunitybio, INC. | $16.69 | 2024 | |
| Photocure INC | $15.75 | 2025 | Cysview |
| Tolmar, INC. | $15.29 | 2023 | |
| Allergan, INC. | $14.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Hunter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.